company background image
BIO

Bio-Rad Laboratories NYSE:BIO Stock Report

Last Price

US$417.14

Market Cap

US$12.4b

7D

-1.1%

1Y

-43.8%

Updated

30 Sep, 2022

Data

Company Financials +
BIO fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance0/6
Financial Health6/6
Dividends0/6

BIO Stock Overview

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

Bio-Rad Laboratories, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bio-Rad Laboratories
Historical stock prices
Current Share PriceUS$417.14
52 Week HighUS$798.97
52 Week LowUS$406.24
Beta0.99
1 Month Change-14.00%
3 Month Change-16.96%
1 Year Change-43.78%
3 Year Change22.92%
5 Year Change84.36%
Change since IPO7,601.05%

Recent News & Updates

Sep 19

Bio-Rad Laboratories hits 52-week low; down 40% YTD

Bio-Rad Laboratories (NYSE:BIO) on Monday hit a 52-week low of $436.90. Year to date, the stock is down ~40%. Over the last year, it is down ~43%. The life science research and clinical diagnostic products company was recently named a top pick in the healthcare sector by Citi.

Sep 02
Is Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt?

Is Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Shareholder Returns

BIOUS Life SciencesUS Market
7D-1.1%-1.9%-2.5%
1Y-43.8%-31.9%-23.2%

Return vs Industry: BIO underperformed the US Life Sciences industry which returned -31.4% over the past year.

Return vs Market: BIO underperformed the US Market which returned -21.5% over the past year.

Price Volatility

Is BIO's price volatile compared to industry and market?
BIO volatility
BIO Average Weekly Movement5.3%
Life Sciences Industry Average Movement9.9%
Market Average Movement6.9%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market2.8%

Stable Share Price: BIO is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: BIO's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19527,900Norman Schwartzhttps://www.bio-rad.com

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.

Bio-Rad Laboratories, Inc. Fundamentals Summary

How do Bio-Rad Laboratories's earnings and revenue compare to its market cap?
BIO fundamental statistics
Market CapUS$12.40b
Earnings (TTM)-US$1.94b
Revenue (TTM)US$2.87b

4.3x

P/S Ratio

-6.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BIO income statement (TTM)
RevenueUS$2.87b
Cost of RevenueUS$1.21b
Gross ProfitUS$1.66b
Other ExpensesUS$3.61b
Earnings-US$1.94b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-65.41
Gross Margin57.92%
Net Profit Margin-67.66%
Debt/Equity Ratio13.3%

How did BIO perform over the long term?

See historical performance and comparison